Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.
about
Algae-based oral recombinant vaccinesPlant-based oral vaccines against zoonotic and non-zoonotic diseasesThe Engineered Chloroplast Genome Just Got SmarterPlant-made oral vaccines against human infectious diseases-Are we there yet?Oral Delivery of Protein Drugs Bioencapsulated in Plant CellsHow can plant genetic engineering contribute to cost-effective fish vaccine development for promoting sustainable aquaculture?Oral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension.Vaccination via Chloroplast Genetics: Affordable Protein Drugs for the Prevention and Treatment of Inherited or Infectious Human DiseasesSuppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cellsInhibitors - cellular aspects and novel approaches for tolerance.Low cost tuberculosis vaccine antigens in capsules: expression in chloroplasts, bio-encapsulation, stability and functional evaluation in vitro.Cloning and Expression of TNF Related Apoptosis Inducing Ligand in Nicotiana tabacum.On the way to commercializing plant cell culture platform for biopharmaceuticals: present status and prospect.Plant-based oral tolerance to hemophilia therapy employs a complex immune regulatory response including LAP+CD4+ T cellsTransgenic carrot expressing fusion protein comprising M. tuberculosis antigens induces immune response in miceEngineered chloroplast dsRNA silences cytochrome p450 monooxygenase, V-ATPase and chitin synthase genes in the insect gut and disrupts Helicoverpa armigera larval development and pupationLow cost industrial production of coagulation factor IX bioencapsulated in lettuce cells for oral tolerance induction in hemophilia B.Oral delivery of Acid Alpha Glucosidase epitopes expressed in plant chloroplasts suppresses antibody formation in treatment of Pompe mice.Expression of the Multimeric and Highly Immunogenic Brucella spp. Lumazine Synthase Fused to Bovine Rotavirus VP8d as a Scaffold for Antigen Production in Tobacco Chloroplasts.Low cost delivery of proteins bioencapsulated in plant cells to human non-immune or immune modulatory cells.Oral-tolerization Prevents Immune Responses and Improves Transgene Persistence Following Gene Transfer Mediated by Adeno-associated Viral Vector.Expression of β-glucosidase increases trichome density and artemisinin content in transgenic Artemisia annua plants.Design of pH-Responsive Biomaterials to Enable the Oral Route of Hematological Factor IXCold chain and virus-free chloroplast-made booster vaccine to confer immunity against different poliovirus serotypes.Oral delivery of bioencapsulated proteins across blood-brain and blood-retinal barriers.From gut to brain: bioencapsulated therapeutic protein reduces amyloid load upon oral delivery.Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice.Progress and future opportunities in the development of vaccines against atherosclerosis.Progress toward inducing immunologic tolerance to factor VIII.Developing inexpensive malaria vaccines from plants and algae.Transgenic plants: a 5-year update on oral antipathogen vaccine development.Activation of human mast cells by retrocyclin and protegrin highlight their immunomodulatory and antimicrobial properties.Current status of viral expression systems in plants and perspectives for oral vaccines development.An overview of tuberculosis plant-derived vaccines.Rice seed for delivery of vaccines to gut mucosal immune tissues.Modification of drug delivery to improve antibiotic targeting to the stomach.Current Developments and Future Prospects for Plant-Made Biopharmaceuticals Against Rabies.In vivo induction of regulatory T cells for immune tolerance in hemophilia.Mucosal vaccine delivery: Current state and a pediatric perspectiveLettuce-produced hepatitis C virus E1E2 heterodimer triggers immune responses in mice and antibody production after oral vaccination.
P2860
Q21131110-2DFEC2B7-CF22-4C0B-9955-A2B432483D39Q26738581-FA71E625-028E-4F42-8D5B-94AD1AA48B56Q26781748-5E6543C8-7CFC-44D9-ABA8-73E057808441Q26783111-3FB89810-0DE1-4723-B4C3-D278CFD9F6EEQ28079063-96001535-2832-4A5E-9D08-574263144AD9Q30393213-D8B36438-6740-476B-BF01-1ABA5551511EQ30600509-7D3D395E-21D3-462E-A18D-0EB76163FA22Q33870122-CB686D7E-4252-4694-AB78-7984B712DE59Q34137024-D61CD5DD-82D0-404F-87F9-2D3377285586Q34380850-8D0C83DB-A2C5-46D3-9264-73D1A98DF605Q34565122-954FC549-54D1-4A31-86EE-703127B6C430Q34777770-5A7A8A98-4DB3-4B9E-8FCC-7B6080B351B7Q35002326-73D1CA10-4F92-47F4-9B3D-39C376E57A83Q35348677-62316190-6200-4F8B-B637-E994861781D4Q35530615-BCC048C0-B51C-4E22-94A4-D23F58B11B26Q35909883-A75A5EFA-32A8-4555-AC43-68202B4B95F7Q36037525-2EBA4A64-2C10-46B1-92AD-1E897ACEDA62Q36083396-4D17DF92-6C1E-48D6-926E-DBBF2C390A0BQ36396478-DD5E160E-36BE-48CF-9555-D4FFFBF14432Q36445623-F6D64D8F-7E84-4DBA-8F93-5DD56B09CE17Q36582796-3208BC4A-FD73-4712-A717-A8A499910DEDQ36619308-FB1D131F-DCB0-4D78-9ADE-FF58476F665EQ36936276-F91AAFB9-8744-4E95-A828-28FAA1E7FE5AQ37324787-74B100B1-01D9-4943-A896-C65688C55DA0Q37620814-E5573AB6-A8CE-4FB2-BD76-D24C1E709EF4Q37620820-FC29BD59-FA05-4F72-B0F7-12AE87EDBE20Q37638227-30C221A0-D9D2-441F-BC38-8A8D6851DD7BQ37835406-BD2433ED-DB60-434B-BA69-5B01159827ACQ38090391-3023D5E6-89C6-4235-8B07-B11594382FD0Q38177668-24403DEA-2299-440C-A8C4-CB685C8A199FQ38243438-BCA0915A-7B80-4C08-AF17-F6605F1ED208Q38285790-0323AE00-C393-4040-8937-01151BA2B5E7Q38307990-253E6A24-A815-4A11-81D9-6B1ED4014BAEQ38356275-DB1A7600-7988-4C4C-8511-697FCA1FBC02Q38534952-2E56B94B-D343-456B-8121-3C0A13E32FC6Q38543395-F9BE5248-567A-4A9F-BE15-F147414BB416Q38545125-55F30D9C-29AE-42C3-B902-6CA68762CF7AQ38574966-3C563B97-90F1-4E70-9ECD-8D712AEBBB12Q38727453-62AD600A-D54E-433F-80B4-0F364122E9CAQ38728810-65008866-AFAE-4707-9C79-DB0FA4D0F3D1
P2860
Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Oral delivery of human biophar ...... ioencapsulated in plant cells.
@ast
Oral delivery of human biophar ...... ioencapsulated in plant cells.
@en
type
label
Oral delivery of human biophar ...... ioencapsulated in plant cells.
@ast
Oral delivery of human biophar ...... ioencapsulated in plant cells.
@en
prefLabel
Oral delivery of human biophar ...... ioencapsulated in plant cells.
@ast
Oral delivery of human biophar ...... ioencapsulated in plant cells.
@en
P2093
P2860
P1476
Oral delivery of human biophar ...... ioencapsulated in plant cells.
@en
P2093
Dheeraj Verma
Kwang-Chul Kwon
Nameirakpam D Singh
Roland Herzog
P2860
P304
P356
10.1016/J.ADDR.2012.10.005
P407
P577
2012-10-23T00:00:00Z